IRIS Accounts Production v24.2.0.383 03848523 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038485232023-03-31038485232024-03-31038485232023-04-012024-03-31038485232022-03-31038485232022-04-012023-03-31038485232023-03-3103848523ns15:EnglandWales2023-04-012024-03-3103848523ns14:PoundSterling2023-04-012024-03-3103848523ns10:Director12023-04-012024-03-3103848523ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3103848523ns10:SmallEntities2023-04-012024-03-3103848523ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3103848523ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3103848523ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3103848523ns10:AbridgedAccounts2023-04-012024-03-3103848523ns10:OrdinaryShareClass22023-04-012024-03-3103848523ns10:OrdinaryShareClass32023-04-012024-03-3103848523ns10:OrdinaryShareClass42023-04-012024-03-3103848523ns10:OrdinaryShareClass52023-04-012024-03-3103848523ns10:Director22023-04-012024-03-3103848523ns10:Director32023-04-012024-03-3103848523ns10:Director42023-04-012024-03-3103848523ns10:RegisteredOffice2023-04-012024-03-3103848523ns5:CurrentFinancialInstruments2024-03-3103848523ns5:CurrentFinancialInstruments2023-03-3103848523ns5:ShareCapital2024-03-3103848523ns5:ShareCapital2023-03-3103848523ns5:RetainedEarningsAccumulatedLosses2024-03-3103848523ns5:RetainedEarningsAccumulatedLosses2023-03-3103848523ns5:FurnitureFittings2023-04-012024-03-3103848523ns5:MotorVehicles2023-04-012024-03-3103848523ns5:DeferredTaxation2023-03-3103848523ns5:DeferredTaxation2023-04-012024-03-3103848523ns5:DeferredTaxation2024-03-3103848523ns10:OrdinaryShareClass22024-03-3103848523ns10:OrdinaryShareClass32024-03-3103848523ns10:OrdinaryShareClass42024-03-3103848523ns10:OrdinaryShareClass52024-03-31
REGISTERED NUMBER: 03848523 (England and Wales)










FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2024

FOR

C D & J H MEDICAL LIMITED

C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2024










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


C D & J H MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2024







DIRECTORS: Dr C D Heath
Mrs J Heath
Mrs K J Heath
Dr C J Heath



REGISTERED OFFICE: c/o Michael Heaven & Associates Limited
47 Calthorpe Road
Edgbaston
BIRMINGHAM
West Midlands
B15 1TH



REGISTERED NUMBER: 03848523 (England and Wales)



ACCOUNTANTS: Michael Heaven & Associates Limited
Chartered Certified Accountants
47 Calthorpe Road
Edgbaston
BIRMINGHAM
B15 1TH



INCORPORATION: 27th September 1999

C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

ABRIDGED BALANCE SHEET
31ST MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 20,631 25,789
Investments 5 19,102 19,102
39,733 44,891

CURRENT ASSETS
Debtors 23,363 19,333
Cash at bank 93,657 78,234
117,020 97,567
CREDITORS
Amounts falling due within one year 86,741 90,223
NET CURRENT ASSETS 30,279 7,344
TOTAL ASSETS LESS CURRENT
LIABILITIES

70,012

52,235

PROVISIONS FOR LIABILITIES 6 5,467 4,900
NET ASSETS 64,545 47,335

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 64,445 47,235
SHAREHOLDERS' FUNDS 64,545 47,335

C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

ABRIDGED BALANCE SHEET - continued
31ST MARCH 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31st March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10th October 2024 and were signed on its behalf by:





Dr C D Heath - Director


C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2024


1. STATUTORY INFORMATION

C D & J H Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the value of services provided to the extent that there is a right to consideration and is recorded at the value of the consideration due.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 20% on reducing balance

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, and loans from related parties.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Creditors
Short term trade creditors are measured at the transaction price.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1st April 2023
and 31st March 2024 50,693
DEPRECIATION
At 1st April 2023 24,904
Charge for year 5,158
At 31st March 2024 30,062
NET BOOK VALUE
At 31st March 2024 20,631
At 31st March 2023 25,789

C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024


5. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1st April 2023
and 31st March 2024 19,102
NET BOOK VALUE
At 31st March 2024 19,102
At 31st March 2023 19,102

The company owns shares in Bromsgrove Healthcare Innovations Limited. A reliable valuation for the shares at the balance sheet date is not available.

6. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 5,467 4,900

Deferred
tax
£   
Balance at 1st April 2023 4,900
Provided during year 567
Movement
Balance at 31st March 2024 5,467

Provisions are recognised when the company has a legal or constructive obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle the obligation and the amount of the obligation can be reliably estimated.

Provisions are recognised at the best estimate of the amount required to settle the obligation at the reporting date.

C D & J H MEDICAL LIMITED (REGISTERED NUMBER: 03848523)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024


7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
10 Ordinary A £1 10 10
34 Ordinary B £1 34 34
33 Ordinary C £1 33 33
23 Ordinary D £1 23 23
100 100

8. RELATED PARTY DISCLOSURES

As at the year end the amount due to the directors totalled £64,107 (2023- £70,757). The loans are interest free and repayable on demand.